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ABSTRACT 
 
The thesis entitled “Application of self-metathesis in the synthesis of bis-
tetrahydrofurans, 1,6-dioxaspiro(4,5)decane spiroketal, ritonavir and lopinavir core 
unit using C2-symmetric approach and synthesis of 8-methoxygoniodiol” is divided 
into three chapters. 
Chapter I: It describes “Stereoselective synthesis of bis-hydroxy tetrahydrofurans using 
cross-metathesis”. 
Chapter II: It is further divided into two sections. 
Section   A:  It deals with “A short approach to the synthesis of ritonavir and 
lopinavir core and its   C-3 epimer via cross metathesis”. 
Section B: It deals with the “Stereoselective synthesis of 1, 6-
dioxaspiro(4.5)decane chiral spiroketal skeleton via C2- symmetric 
approach using  cross-metathesis”. 
Chapter III: It describes the “stereoselective synthesis of 8-methoxygoniodiol”. 
 
CHAPTER I 
It describes the “Stereoselective synthesis of bis-hydroxy tetrahydrofurans using 
cross-metathesis”. The annonaceous acetogenins are a family of almost 400 natural 
products, which have been found in 37 different species of annonaceous plants. A 
remarkably broad spectrum of biological activity has been reported for these agents, 
including cytotoxic, antitumor, antimalarial, pesticidal, antifeedent and most importantly, 
in vivo antitumor behavior. They have also been shown to be active against multidrug-
resistant tumors. Biogenetically, the acetogenins are characterized by a long lipophilic 
tail, a central polyoxygenated core, and a terminal α,β-unsaturated γ-lactone. Diversity 
within this family arises principally from variations in stereochemistry, the location of the 
THF and THP units and various hydroxylation patterns. 
An important structural feature that appears in most of the annonaceous 
acetogenins having high biological activity is a C10 fragment containing two adjacent bis-
THF groups, flanked by two hydroxy groups. Usually the two THF rings are linked in a  
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threo arrangement with trans substituents at the 1,5-positions. The crucial component in 
the synthesis of any of these natural products is the stereoselective preparation of the 
polyoxygenated central fragment, i.e., the adjacent dihydroxy bis-THF unit (figure 1). 
Taking the above into consideration we undertook the synthesis of polyoxygenated 
central bis tetrahydrofuran motif 1, by employing self cross-metathesis, Sharpless 
asymmetric dihydroxylation and acid catalyzed cyclisation reactions as key steps.   
The general features of our approach to bis tetrahydrofuran core 1 is illustrated in 
retro synthetic format in scheme 1. 
Scheme 1: 
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Accordingly, our synthesis commenced from readily available p-anisaldehyde 7. 
The Grignard reaction of anisaldehyde with homoallylmagnesium bromide in THF 
afforded the free hydroxy compound 8. Here to our dismay the self metathesis of olefin 8 
was unsuccessfull with Grubbs’ I and II generation catalysts. Then we tried to explore the 
self metathesis by protecting the free hydroxy function in compound 8. Thus, the hydroxy 
compound 8 was treated with aceticanhydride, TEA in DCM yielded the acetate 
derivative 6. Now the acetate compound underwent self metathesis with Grubbs’ I 
generation catalyst in DCM to afford the dimer compound 5 exclusively as E isomer. 
This dimer olefin 5 subjected to Sharpless asymmetric dihydroxylation conditions with 
AD Mix β in tert-BuOH-H2O afforded the dimeric syn diol 4. The crucial cyclisation of 4 
was carried out with trifluoroacetic acid in dichloromethane at 0 °C for 4 h to give single 
isomer 3 via SN1 fashion. The oxidative cleavage of aromatic ring in 3 to its 
corresponding acid derivative 9 was unsuccessful with RuO4 under different conditions 
(scheme 2). 
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Reagents and conditions: (a) ) CH2=CH-CH2-CH2MgBr, THF, 0 oC-rt, 5 h, 80 %; (b) (CH3CO)2O, TEA, 
DMAP, DCM, 0 oC to rt, 3 h, 90%; (c) 10 mol% Grubbs’ 1st generation catalyst, DCM, 40 oC, 12 h, 85 %; 
(d) AD mix-β, H2O: t-BuOH (1:1) 0 oC, 12 h, 75%; (e) TFA, DCM, rt, 4 h, 72 %; (f) RuCl3, NaIO4, CCl4: 
EA:H2O, rt, 12 h.  
 
The conformation of the THF unit 3 is fixed by considering the observed coupling 
constants and NOEs.  The J H2-H3b=11.3 Hz and the weak NOE between these protons 
confirms that they are in trans to each other. Furthermore the strong NOE cross peaks 
between H2-H4a, H2- H5 and H5-H4a suggested that these protons are in same plane. In 
addition to these NOEs other NOE cross-peaks, Ho- H3b , Ho- H3a , Ho-H2  and Hm- CH3 
confirms the structure of the  molecule as shown in figure 2. 
Figure 2: NOE observations of compound 3 
 
 
 
 
 
 
 
 
 
Inorder to overcome the difficulty of scheme 2 we changed our strategy to 
complete the bis hydroxy tetrahydrofuran unit 2 using self metathesis, Sharpless 
asymmetric dihydroxylation and SN2 cyclisation as shown in scheme 3.  
We envisaged that the bis- tetrahydrofuran unit 3 can be prepared from C2-
symmetric diol 10 via nucleophilic substitution reaction (SN2). This C2-symmetric diol 10 
can obtained from dimer olefin 11 compound by applying Sharpless asymmetric 
dihydroxylation protocol using AD Mix β. The dimer olefin compound 11 can be derived 
from single olefin monomer unit 12 by subjecting to Grubbs’ olefin metathesis conditions 
using first generation catalyst. The olefin compound 12 can be obtained from epoxide 13, 
by regioselective opening with allyl magnesium bromide. This oxirane 13 can obtained 
from L-Ascorbic acid 14 in six steps using standard conditions. 
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Scheme 3: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The synthesis commenced from L-Ascorbic acid (vitamin C) 14. The saturated 
diol function of ascorbic acid 14 was easily protected as acetonide 15 by dissolving 14 in 
excess acetone containing catalytic amount of acetyl chloride.  
Scheme 4: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reagents and conditions: (a) AcCl, acetone 0 oC-rt, 14 h; (b) H2O2, K2CO3, H2O, 0 oC-rt ,12 h; (c) EtI, 
ACN, reflux, 15 h, 85 % (for three steps); (d) LiAlH4, THF, 0 oC-rt, 1 h, 95 %; (e) i, p-TsCl, Py,  0 oC, 12 h, 
ii, K2CO3, MeOH, 0 oC-rt, 2 h, 75 % (for two steps).    
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The enone moiety in acetonide 15 was cleaved using H2O2, K2CO3 to afford 
potassium salt 16, which on treatment with ethyl iodide in acetonitrile at reflux conditions 
afforded ester 17 in good yield. In the presence of LAH in THF the ester functionality 
was reduced to diol 18. The primary hydroxy in diol 18 selectively converted to its tosyl 
derivative using p-TsCl, TEA in DCM and was used as such with out purification. This 
tosyl compound treated with K2CO3 in MeOH afforded the epoxide 13 smoothly (scheme 
4). 
 
Regioselective opening of epoxide 13 using allylmagnesium bromide gave 
homoallylic alcohol 19 in good yield. The key cross metathesis reaction of olefin 19 
using Grubbs’ first-generation olefin metathesis catalyst (10 mol %) afforded the C2 
symmetric compound 11b as an inseparable E, Z mixture of isomers in a ratio of 85:15. 
In order to improve the E-selectivity, the cross metathesis reaction was carried out with 
substrates 20 and 21 which posses electron withdrawing groups to give compounds 11a 
and 11c in good yields with E:Z isomer ratios of 93:7 and 70:30, respectively. From the 
above comparative study it was interesting to note that acetate protection gave the best 
E/Z isomer ratios (in favour of the E – isomer).  
Scheme 5: 
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Reagents and conditions: (a) CH2=CH-CH2MgBr, CuI, ether, -20 oC, 12 h, 85%; (b) (CH3CO)2O, TEA, 
DMAP, DCM, 0 oC to rt, 3 h, 90%; (c) p-TsCl, TEA, DMAP, DCM, 0 oC to rt, 24 h, 87%; (d) 10 mol% 
Grubbs’ 1st generation catalyst, DCM, 40 oC, 12 h, for 11a 90%,for 11b 85%,for 11c 82%; (e) K2CO3, 
methanol, 0 oC to rt, 2 h, 85%; (f) p-TsCl, TEA, DMAP, DCM, 0 oC to rt, 36 h, 87%; (g) AD mix-β, H2O: t-
BuOH (1:1) 0 oC, 12 h, 85%; (h) NaH, THF, 0 oC to rt, 6 h, 80%;  
 
Accordingly, compound 11a upon treatment with K2CO3 in MeOH gave C2-
symmetric diol 11b which was converted to di-tosylate 11c using p-toluenesulphonyl 
chloride and triethylamine in DCM. Compound 11c upon Sharpless asymmetric 
dihydroxylation (SAD) using AD-mix-β afforded diol 10. Finally cyclisation of 10 using 
NaH in THF furnished the desired compound 2 after column chromatography as light 
yellow syrup in 80% yield (scheme 5). 
In conclusion, we have demonstrated a short asymmetric approach for the 
synthesis of a dihydroxy bis-tetrahydrofuran unit via cross-metathesis. It was also 
observed in the above case that the presence of an acetate protecting group gave a better 
E/Z isomer ratio in comparison to a tosyl group and the unprotected hydroxy group in 
cross metathesis 
 
CHAPTER II 
Section A: 
It deals with “A short approach to the synthesis of ritonavir and lopinavir core and 
its   C-3 epimer via cross metathesis”. Acquired immunodeficiency syndrome (AIDS), a 
degenerative disease of the immune system, is one of the most challenging problems in 
the medicine. Among various strategies to combat this disease, therapeutic inhibition of 
the virally encoded HIV protease became an attractive target. The treatment of HIV and 
AIDS was revolutionalized by the introduction of peptido mimetic aspartyl protease 
inhibitors.  
Even though there are six protease inhibitors the ritonavir 22 (trade name 
“norvir”, ABT-538) and lopinavir 23 (trade name “aluviran”, ABT-378) are FDA 
approved clinically effective peptidomimetic HIV protease inhibitors from Abbott 
laboratories with high oral bioavailability (figure 3).  
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In addition to above inhibitors, specially, the recognition of HIV protease exists in 
its active form as a C2-symmetric homodimer has prompted interest in the potential utility 
of C2-symmetric compounds as novel inhibitors (the symmetric molecule inhibited both 
protease activity and acute HIV-1 infection in vitro, was at least 10,000-fold more potent 
against HIV-1 protease than against related enzymes and appeared to be stable to 
degradative enzymes). Accordingly, the C2 symmetric diaminodiol core containing 
inhibitors such as A-76928 24 is under clinical trials (figure 4).   
Figure 4: 
  
 
 
 
 
 
 
 
 
 
Due to high biological importance we paid attention to undertake a stereoselective 
synthesis of both Phe-Phe hydroxyethylene core unit 25 of ritonavir 22 and lopinavir 23, 
its C-2 epimer 26 and diamino diol core unit 27 of A-76928 24 (figure 4). Inspite of many 
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synthesis reported for these core units, almost all are fraught with long reaction sequence. 
In order to circumvent these large step strategies coupled with an objective to device a 
simple protocol, a new synthetic approach for these units was undertaken and here in we 
describe a short and simple approach for these core units from commercially available L-
Phenylalanine via self cross-metathesis and Sharpless asymmetric dihydroxylation 
protocols. 
Figure 5: 
 
 
 
 
 
The general features of our approach to Phe-Phe hydroxyethylene core unit 25 its 
C-2 epimer 26 and diamino diol core unit 27 are illustrated in retro synthetic format in 
scheme 6. 
Scheme 6: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
We envisioned that the diamino alcohols 25, 26 and diamino diol 27 units can be 
obtained from by using appropriate reagents as shown in scheme 6. The compound 28 
can be obtained by dimeristion of olefin 29 a single monomer unit under self cross 
metathesis conditions with Grubbs’ catalyst.  
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This olefin 29 un turn can be obtained from corresponding aldehyde, which can 
be prepared from L-phenylalaninol 30. The L-phenylalaninol 30 can be easily derived 
from natural amino acid L-phenylalanine 31 by using established procedure. The diamino 
diol 27 can be derived from C2-symmetric olefin 28 with Sharpless asymmetric 
dihydroxylation conditions. 
Accordingly, the synthesis commenced from commercially available amino acid 
L-phenylalanine 31. Reaction of L-phenylalanine 31 (scheme 7) with acetyl chloride in 
refluxing methanol afforded its methylester hydrochloride 32. The crude ester 32 on 
treatment with triethylamine in THF at 0 oC generated the free amine, which was in situ 
derivatized as its N-Boc ester 33 in quantitative yield. The ester functionality in 
compound 33 was reduced using LiBH4 (prepared in situ from anhydrous LiCl and 
NaBH4 in ethanol) in THF to give alcohol 30 in 82 % as a white solid.  
Scheme 7: 
 
 
 
 
 
 
 
 
 
 
Reagents and conditions: (a) AcCl, MeOH, reflux, 3 h; (b) (Boc)2O, Et3N, THF, rt, 7 h (95% for two 
steps); (c) LiCl, NaBH4, EtOH, THF, rt, 16 h, 82%; 
 
This alcohol 30 was subjected to Swern oxidation conditions using (COCl)2, 
DMSO in DCM to give aldehyde, which was taken as such to the next step without 
purification. To our dismay, one carbon extension of aldehyde to olefin compound was 
unsuccessful under standard Wittig protocol. Finally olefin 29 was obtained by Takai-
Nozaki olefination conditions in 55% overall yield (for two steps). The key cross 
metathesis reaction of olefin 29 using Grubbs’ second generation olefin metathesis 
catalyst (10 mol %) afforded C2-symmetric dimer 28 as E isomer exclusively, where as 
with first generation Grubbs’ catalyst failed to give the product in our hand.  Although 
alkene 28 was reported in literature and synthesized using Julia olefination but it involves 
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more no of steps and reagents like n-butyllithium, Na/Hg amalgam and Na liq. NH3, 
which resulted in low yields of the product. Therefore their approach has limitation to 
large scale synthesis. Hydroboration of olefin 28 with BH3.DMS in THF gave the 
required alcohols 27 and 26 in 3.8:1 ratio as separable mixture and its spectral data were 
in good agreement with reported values (scheme 8). 
Scheme 8: 
 
 
 
 
 
 
 
 
 
 
 
 
Reagents and conditions: (a) i) DMSO, (COCl)2, DCM, -78 oC, 2 h then TEA; ii) Zn, CH2I2, Ti (OiPr) 4, 
THF, rt, 1 h, 55% (for two steps); (b) 10 mol% Grubbs’ IInd Generation catalyst, DCM, 40 oC, 14 h, 87%; 
(c) BH3-DMS, H2O2, NaOH, THF, 0 oC to rt , 8 h, 70%;  
 
In order to get exclusively either of the isomers, oxidation and reduction protocol 
was applied on mixture of 25 and 26 (scheme 9). Dess-Martin periodinane oxidation of 
the secondary alcohol function of 25 and 26 in DCM led to the keto compound 34. 
Reduction of the keto compound 34 with NaBH4 in MeOH gave anti alcohol 26 as major 
isomer in 9:1 ratio, where as reduction with ZnBH4 in THF afforded syn alcohol 25 as 
major isomer in 8:2 ratio. To get the C2 symmetric diol we subjected the olefin compound 
28 was subjected to dihydroxylation under Sharpless asymmetric conditions with AD 
Mix-β in t-BuOH:H2O (1:1) which afforded the  anti diol 27 exclusively and its spectral 
data were in good agreement with reported values.  
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Scheme 9: 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reagents and conditions: (a) Dess-Martin periodinane, DCM, 0 oC to rt, 3 h, 80%; (b) ZnBH4, THF, 0 oC 
to rt, 5 h, 75%; (c) NaBH4, MeOH, 0 oC to rt, 3 h, 80%; (d) AD mix-β, H2O: t-BuOH (1:1) 0 oC, 12 h, 85%; 
 
In conclusion, we demonstrated here a short and common approach for the 
synthesis of phe-phe hydroxyethylene isostere 25 a core unit of ritonavir and lopinavir, its 
C-3 epimer 26 and diol 27 from C2 symmetric dimer 28, which was obtained from a 
single monomer using self-metathesis. 
Section B: 
It deals with the “Stereoselective synthesis of 1, 6-dioxaspiro(4.5)decane chiral 
spiroketal skeleton via C2- symmetric approach using  cross-metathesis”. Spiroketals are 
widely distributed in nature and exists in a wide range of natural products of varying 
complexity. Spiroketals perticularly 1,7-dioxaspiro(5.5)undecane and the 1,6-
dioxaspiro(4.5)decane systems are subunits of many biologically active compounds such 
as polyether ionophores, insect pheromones and antibiotic macrolides.  The source of 
these is includes insects, microbes, plants, fungi and marine organisms. The novel 
structural features of these spiroketals attracted the attention of both biologists and 
synthetic organic chemists all over the world and several approaches have been 
developed for their synthesis. A recent report reveals that even poorly substituted 
spiroketals exhibit biological effects such as tublin modulation (Spiket P) and 
cytotoxicity against tumor cell lines (figure 6). 
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Although approaches for the synthesis of 1,6-dioxaspiro(4.5)decane 35 system are 
reported earlier but most of them had long reaction sequence and does not involve good 
selectivities. Therefore we developed a new approach having concise, versatile reaction 
sequences, which involve cross-metathesis and acid catalyzed cyclisation reactions via 
C2-symmetric substrate. This strategy of making C2-symmetric compounds from a single 
substrate in a single step has an advantage over conventional approach, which requires 
more than one substrate thus leading to more number of manipulations. Infact the self 
metathesis strategy falls under the one of the principles of green chemistry. 
The general features of our approach to 1,6-dioxaspiro(4.5)decane spiroketal unit 35 is 
illustrated in retro synthetic format in scheme 10. 
      As shown in the retrosynthetic analysis (scheme 10), we envisaged that 1, 6-
dioxaspiro(4.5)decane unit 35, could be synthesized from  spiroketalisation of pseudo C2 
symmetric keto compound 36 . This keto compound can be derived from its 
corresponding alcohol 37, which in turn can be prepared from C2 symmetric olefin 38 
under hydroboration conditions. The key intermediate in our synthesis that is the dimer 
olefin compound 38, which can be obtained from self cross-metathesis of single 
monomer olefin 39 using Grubbs’ olefin metathesis catalyst. This olefin compound 39 
can be prepared easily from chiral oxirane 40 in two steps. 
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Scheme 10: 
 
 
 
. 
 
 
 
 
 
 
 
 
 
 
Accordingly, the synthesis (scheme 11) of 1, 6-dioxaspiro(4.5)decane unit 35 
commenced from commercially available benzylglycidyl ether 41. The recemic terminal 
epoxide was subjected to solvent free hydrolytic kinetic resolution by employing 0.005 
mol% (salen)Co(III)(OAc ) complex (Jacobson catalyst) to afford the chiral oxirane 40 in 
good yield. The regioselective opening of epoxide 40 using allylmagnesiumbromide gave 
alcohol 42, the alcohol functionality in 42 was protected as methoxymethyl ether to get 
the olefin 39 using methoxymethyl chloride and diisopropylethylamine in DCM. The key 
cross metathesis reaction of olefin 39 using Grubbs’ first generation olefin metathesis 
catalyst (10 mol %) afforded C2-symmetric dimer compound 38 as inseparable E, Z 
mixture with ratio of E:Z = 9:1, which was identified by proton integration values in 
1HNMR and carried to the next step without their separation.  Hydroboration of olefin 38 
yielded the alcohol 37. This was converted to keto compound 36 using Dess-Martin 
periodinane. The spiroketalization of ketone 36 by treating with conc. HCl in MeOH 
gave cyclised compound 43. Finally the deprotection of benzyl group was achieved by 
applying Li/liq NH3 conditions to afford the desired compound 35, as colorless liquid in 
90% yield, whose physical and spectral data were in good agreement with reported 
values. 
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Scheme 11: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reagents and conditions: (a) (R,R)-(salen)Co(III)(OAc ) complex, H2O, toluene, rt, 12 h. 42 %; (b) 
CH2=CH-CH2MgBr, CuI, Ether,-20 oC, 12 h, 87%; (c) MOM-Cl, DIPEA, DMAP, DCM, 0 oC to rt, 4 h, 
90%; (d) 10 mol% Grubbs 1st Generation catalyst, DCM, 40 oC, 12 h, 94%; (e) BH3-DMS, H2O2, NaOH, 
THF, 0 oC to rt , 8 h, 85%; (f) Dess-Martin periodinane, DCM, 0 oC to rt, 3 h, 88%; (g) Conc. HCl, MeOH, 
40 oC, 10 min 92%; (h) Na in liq. NH3, THF, -78 oC, 5 h, 85%; 
 
In conclusion, we demonstrated here a short asymmetric and common approach 
for the synthesis of 1, 6-dioxaspiro(4.5)decane chiral spiroketal system from only one 
starting material using self-metathesis and acid catalyzed cyclisation.  
 
CHAPTER III 
It describes the “Stereoselective synthesis of 8-methoxygoniodiol”. Lactone rings 
are the structural features of many natural products. Of the naturally occurring lactones, 
which all display a wide range of pharmacological activities, those bearing a 5,6-
dihydropyran-2-one moiety are relatively common in various types of natural sources. 
5,6-dihydropyran-2-ones of both natural and non-natural origin have been found to be 
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cytotoxic. The pyranone units are widely distributed in all parts of plants (Lamiaceae, 
Piperaceae, Lauraceae, and Annonaceae families) including leaves, stems, flowers, and 
fruits. Styryllactones with pyronones unit are common feature of Goniothalamus family. 
 Thirty-one bioactive styryl-lactones, with six different basic skeletons, have been 
isolated from Goniothalamus species till now, 8-methoxygoniodiol 44 is one among them 
(figure 7). 
Figure 7: 
 
 
 
 
 
 
 Intriguing biological profiles and impressive molecular structure of 44 attracted 
us to synthesise the 8-methoxygoniodiol 44, isolated from stems and leaves of 
Goniothalamus amuyon. The seeds of Goniothalamus amuyon are reported to be useful 
for the treatment of edema and rheumatism. In addition to that this 8-methoxygoniodiol 
found to possess significant cytotoxicity against several human tumors. The key features 
of our approach to 8-methoxygoniodiol 44 are illustrated in the retro synthetic format 
(scheme 12). 
We envisioned that the 8-methoxygoniodiol 44 can be prepared from cis α,β-
unstaurated ester compound 45 via acid mediated, acetonide deprotection followed by 
lactonisation in one pot. The ester can be obtained from its corresponding alcohol 46 by 
DMP oxidation and Horner-Wadsworth-Emmons reaction. This alcohol 46 in turn can be 
prepared from hydroxy compound 47 by usual protection and deprotection process. The 
hydroxyl compound 47 can obtained from diol 48 in four steps. This diol can be prepared 
from compound 49 by employning Sharpless asymmetric dihydroxylation protocol. This 
olefine can be derived from propanediol 50 using standard reactions. 
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Scheme 12:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accordingly, our synthesis of 8-methoxygoniodiol 44 commenced from 
commercially available propanediol 50. One of the hydroxy group in 50 was protected as 
its benzyl ether using BnBr, NaH in DMF to give compound 51. The alcohol compound 
51 was subjected to Swern oxidation using DMSO, (COCl)2 and Et3N to give aldehyde, 
this aldehyde was subjected to Wittig protocol with phenacyl triphenylphosporane 
(PhCOCHPPh3) in DCM to give stereoselectively trans α,β-unsaturated ketone 49 as a 
yellow colour liquid along with cis isomer as separable mixture in 8:2 ratio. This trans 
compound 49 was subjected to modified Sharpless asymmetric dihydroxylation 
conditions using AD Mix β in tert-BuOH-H2O to afford the syn diol 48. The diol 
compound 48 underwent acetonide protection using 2,2-DMP and p-TSA (cat) in DCM 
to give acetonide  protected compound 52 (scheme 13).  
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Scheme 13: 
  
 
 
 
 
 
 
 
 
Reagents and conditions: (a) NaH, BnBr, DMF, 0 °C-rt, 8 h, 70%; (b) i. DMSO, (COCl)2, DCM, -78 °C, 
2 h then Et3N; ii. PhCOCHPPh3, DCM, rt, 6 h, 78%; (c) AD Mix β, tert-BuOH-H2O,NaHCO3, 0 °C, 8 h, 82 
%; (d) 2,2-DMP, p-TSA, DCM, rt, 4 h,  90 %. 
 
    
 
The keto functionalty in 52 was reduced with NaBH4 but the diastereoselectivity 
was not good (6:4 ratio). In order to the get good selectivity the compound 52 with K-
selectride in THF to afford the syn hydroxy compound 53 in excellent selectivity. The out 
come was explained based on the Crams chelation model.  To get the required anti 
alcohol, we conducted Mitsunobu inversion on 54, with DIAD, in presence of p-nitro 
benzoic acid, TPP in THF to yield the ester compound 54 with inversion 
configuration.The ester 54 was underwent hydrolysis with K2CO3 in MeOH to give the 
anti alcohol compound 47. The alcohol functionality was converted to its methyl ether 
using methyl iodide and NaH in THF to give the methoxy derivative 55 in good yield 
(scheme 14). 
Schem 14. 
 
 
 
 
 
 
 
 
 
Reagents and conditions: (a) K-Selectride, THF, -78 oC, 3 h, 70 %; (b) DIAD, TPP, p-NBA, rt,  6 h, 80 
%; (c) K2CO3, MeOH,  0 oC-rt, 3 h, 83 %; (d) MeI, NaH, 0 oC-rt, 4 h, 90 %. 
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The benzyl protection in compound 55 was removed by using Pd/C, ethylacetate 
in presence of H2 gas to give the primary hydroxy compound 46. The free hydroxy group 
in 46 was oxidized using Swern oxidation conditions to afford the aldehyde, which was 
used to next step as such. To this aldehyde, ylide was added slowly at -78 oC, (ylide was 
generated freshly by treatment of bis-2, 2, 2 trifluromethyl (methoxy carbonyl methyl) 
phosphonate with NaH at 0 oC) affording the cis α,β-unstaurated ester 45 as exclusively 
z-isomer. When the α,β-unstaurated ester compound 45 was treated with p-TSA (Cat) in 
benzene, acetonide deprotection followed by lactonisation occurred in one pot to give 
desired product 8-methoxygoniodiol 44. The spectral data of 44 was in good agreement 
with the reported values (scheme 15). 
 
Scheme 15:  
 
 
 
 
 
 
 
 
 
 
 
 
 
Reagents and conditions: (a) Pd/C, H2, ethylacetate, 12 h, 89 %; (b) i, DMSO, (COCl)2, DCM, -78 °C, 2 h 
then Et3N; ii. (CF3CH2O)2P(O)CH2CO2Me, NaH, THF, 0 oC-rt, 2 h, 63 % (for two steps); (c) p-TSA, 
benzene, rt, 6 h, 80 %.  
 
In conclusion we have developed an enantioselective synthesis of 8-
methoxygoniodiol 44 using Sharpless asymmetric dihydroxylation and the strategy is 
very much useful to prepare the different analogues of 8-methoxygoniodiol for more 
therapeutic values.  
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